Pharmaceuticals

AI-Enabled Drug Repositioning Project Is Playing A Role In Shaping The Phosphoramidite Market

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Phosphoramidite Market Be By 2030 Compared To Its 2026 Market Size?

The phosphoramidite market has witnessed substantial expansion in recent years. It is anticipated to grow from $1.07 billion in 2025 to $1.15 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. The historical increase can be attributed to factors such as a surge in DNA sequencing activities, greater academic research funding, the increased use of synthetic nucleic acids, the development of solid-phase synthesis techniques, and rising demand for molecular diagnostics.

The phosphoramidite market is projected to experience robust expansion over the coming years. By 2030, its valuation is forecast to reach $1.5 billion, demonstrating a compound annual growth rate (CAGR) of 6.9%. This anticipated growth during the forecast timeframe is primarily driven by factors such as the broadening scope of RNA-based treatments, advancements in gene editing technologies, increased funding for pharmaceutical research and development, a growing need for customized oligonucleotides, and the scaling up of automated synthesis systems. Key trends emerging over the projection period encompass an escalating requirement for materials used in oligonucleotide synthesis, the widening application of gene therapy and RNA therapeutics, expanded utilization in both diagnostic and research contexts, the increasing embrace of automated solid-phase synthesis, and a heightened emphasis on chemical inputs of superior purity.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

What Significant Factors Are Influencing The Phosphoramidite Market Expansion?

The phosphoramidite market is anticipated to see growth propelled by the expansion of the biopharmaceutical sector. This sector involves the research, development, production, and commercialization of biologically derived medical products, such as vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The enlargement of the biopharmaceutical sector stems from advancements in biotechnology, an increase in the prevalence of chronic diseases, and rising investments in research and development. Biotechnology innovations like gene editing and monoclonal antibody therapies have led to more effective and targeted treatments. For instance, the Office for National Statistics, a UK-based government department, reported in October 2025 that in 2024, the UK life sciences industry comprised 6,170 businesses operating across 7,320 sites, employing 359,600 people and generating $191 billion (£146.9 billion) in turnover. The medical technology subsector was the largest, representing 60% of all companies and 55% of total employment. Therefore, the expansion of the biopharmaceutical sector is a significant driver for the growth of the phosphoramidite market.

How Is The Phosphoramidite Market Categorized Across Its Segment Groups?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

What Trends Are Affecting The Growth Of The Phosphoramidite Market?

Within the phosphoramidite market, prominent companies are increasingly focused on developing advanced DNA synthesis methods, such as utilizing convertible-preferred stock financing rounds, to boost the adoption and progress of Gibson SOLA technology for rapid DNA and mRNA synthesis. Convertible-preferred stock financing is defined as a capital-raising technique where a company issues preferred shares that have the option to be converted into a predetermined number of common shares later on. For example, in March 2025, Telesis Bio Inc., a US-based biotechnology company, announced it had secured up to $21 million in new financing, supported by several strategic investors, to speed up the commercialization of its next-generation enzymatic DNA synthesis platform, Gibson SOLA. This funding is designed to scale the company’s fully enzymatic DNA synthesis technology, expand its R&D and manufacturing capabilities, and broaden access to rapid, customizable long-DNA production. The company employs a unique enzymatic approach that allows for the fast and precise synthesis of long DNA sequences, thereby addressing current limitations found in traditional phosphoramidite-based methods.

Which Firms Are Influencing Competition In The Phosphoramidite Market?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Get The Full Phosphoramidite Market Report:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Region Holds The Highest Market Share In The Phosphoramidite Market?

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Phosphoramidite Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Browse Through More Reports Similar to the Global Phosphoramidite Market 2026, By The Business Research Company

Phosgene Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosgene-global-market-report

Phosphoric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphoric-acid-global-market-report

Phosphonates Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphonates-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795